These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 28399844)

  • 1. Implementation of a pragmatic randomized trial of screening for chronic kidney disease to improve care among non-diabetic hypertensive veterans.
    Peralta CA; Frigaard M; Rubinsky AD; Rolon L; Lo L; Voora S; Seal K; Tuot D; Chao S; Lui K; Chiao P; Powe N; Shlipak M
    BMC Nephrol; 2017 Apr; 18(1):132. PubMed ID: 28399844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for CKD To Improve Processes of Care among Nondiabetic Veterans with Hypertension: A Pragmatic Cluster-Randomized Trial.
    Peralta CA; Frigaard M; Rolon L; Seal K; Tuot D; Senyak J; Lo L; Powe N; Scherzer R; Chao S; Chiao P; Lui K; Shlipak MG; Rubinsky AD
    Clin J Am Soc Nephrol; 2020 Feb; 15(2):174-181. PubMed ID: 32034070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a Primary Care CKD Registry in a US Public Safety-Net Health Care Delivery System: A Pragmatic Randomized Trial.
    Tuot DS; McCulloch CE; Velasquez A; Schillinger D; Hsu CY; Handley M; Powe NR
    Am J Kidney Dis; 2018 Aug; 72(2):168-177. PubMed ID: 29699885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electronic Decision Support for Management of CKD in Primary Care: A Pragmatic Randomized Trial.
    Peralta CA; Livaudais-Toman J; Stebbins M; Lo L; Robinson A; Pathak S; Scherzer R; Karliner LS
    Am J Kidney Dis; 2020 Nov; 76(5):636-644. PubMed ID: 32682696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacist based intervention to improve the care of patients with CKD: a pragmatic, randomized, controlled trial.
    Cooney D; Moon H; Liu Y; Miller RT; Perzynski A; Watts B; Drawz PE
    BMC Nephrol; 2015 Apr; 16():56. PubMed ID: 25881226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Pragmatic Cluster Randomized Trial of an Electronic Clinical Decision Support System to Improve Chronic Kidney Disease Management in Primary Care: Design, Rationale, and Implementation Experience.
    Khoong EC; Karliner L; Lo L; Stebbins M; Robinson A; Pathak S; Santoyo-Olsson J; Scherzer R; Peralta CA
    JMIR Res Protoc; 2019 Jun; 8(6):e14022. PubMed ID: 31199334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.
    Chang AR; Evans M; Yule C; Bohn L; Young A; Lewis M; Graboski E; Gerdy B; Ehmann W; Brady J; Lawrence L; Antunes N; Green J; Snyder S; Kirchner HL; Grams M; Perkins R
    BMC Nephrol; 2016 Nov; 17(1):168. PubMed ID: 27825313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 2 Clinical Decision Support Strategies on Chronic Kidney Disease Outcomes in Primary Care: A Cluster Randomized Trial.
    Carroll JK; Pulver G; Dickinson LM; Pace WD; Vassalotti JA; Kimminau KS; Manning BK; Staton EW; Fox CH
    JAMA Netw Open; 2018 Oct; 1(6):e183377. PubMed ID: 30646261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving chronic kidney disease detection and treatment in the United States: the chronic kidney disease cascade of care (C
    Lamprea-Montealegre JA; Joshi P; Shapiro AS; Madden E; Navarra K; Potok OA; Gregg LP; Podchiyska T; Robinson A; Goldstein MK; Peralta CA; Jassal SK; Navaneethan SD; Rifkin DE; Wang V; Shlipak MG; Estrella MM
    BMC Nephrol; 2022 Oct; 23(1):331. PubMed ID: 36224528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Clinical Decision Support to Improve Primary Care Identification and Management of Chronic Kidney Disease (CKD).
    Litvin CB; Hyer JM; Ornstein SM
    J Am Board Fam Med; 2016; 29(5):604-12. PubMed ID: 27613793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pragmatic clinic randomized trial to improve chronic kidney disease care: Design and adaptation due to COVID disruptions.
    Sperl-Hillen JM; Crain AL; Chumba L; Ekstrom HL; Appana D; Kopski KM; Wetmore JB; Wheeler J; Ishani A; O'Connor PJ
    Contemp Clin Trials; 2021 Oct; 109():106501. PubMed ID: 34271175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concordance With Screening and Treatment Guidelines for Chronic Kidney Disease in Type 2 Diabetes.
    Edmonston D; Lydon E; Mulder H; Chiswell K; Lampron Z; Marsolo K; Goss A; Ayoub I; Shah RC; Chang AR; Ford DE; Jones WS; Fonesca V; Machineni S; Fort D; Butler J; Hunt KJ; Pitlosh M; Rao A; Ahmad FS; Gordon HS; Hung AM; Hwang W; Bosworth HB; Pagidipati NJ
    JAMA Netw Open; 2024 Jun; 7(6):e2418808. PubMed ID: 38922613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The veterans' study to improve the control of hypertension (V-STITCH): design and methodology.
    Bosworth HB; Olsen MK; Goldstein MK; Orr M; Dudley T; McCant F; Gentry P; Oddone EZ
    Contemp Clin Trials; 2005 Apr; 26(2):155-68. PubMed ID: 15837438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electronic Health Record Population Health Management for Chronic Kidney Disease Care: A Cluster Randomized Clinical Trial.
    Jhamb M; Weltman MR; Devaraj SM; Lavenburg LU; Han Z; Alghwiri AA; Fischer GS; Rollman BL; Nolin TD; Yabes JG
    JAMA Intern Med; 2024 Jul; 184(7):737-747. PubMed ID: 38619824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD.
    Navaneethan SD; Akeroyd JM; Ramsey D; Ahmed ST; Mishra SR; Petersen LA; Muntner P; Ballantyne C; Winkelmayer WC; Ramanathan V; Virani SS
    Clin J Am Soc Nephrol; 2018 Dec; 13(12):1842-1850. PubMed ID: 30498000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrology co-management versus primary care solo management for early chronic kidney disease: a retrospective cross-sectional analysis.
    Samal L; Wright A; Waikar SS; Linder JA
    BMC Nephrol; 2015 Oct; 16():162. PubMed ID: 26458541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
    Wu LS; Chang SH; Chang GJ; Liu JR; Chan YH; Lee HF; Wen MS; Chen WJ; Yeh YH; Kuo CT; See LC
    Cardiovasc Diabetol; 2016 Apr; 15():56. PubMed ID: 27039185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of Chronic Kidney Disease Management in Canadian Primary Care.
    Bello AK; Ronksley PE; Tangri N; Kurzawa J; Osman MA; Singer A; Grill AK; Nitsch D; Queenan JA; Wick J; Lindeman C; Soos B; Tuot DS; Shojai S; Brimble KS; Mangin D; Drummond N
    JAMA Netw Open; 2019 Sep; 2(9):e1910704. PubMed ID: 31483474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provision of care for chronic kidney disease by non-nephrologists in a developing nation: a national survey.
    Al Shamsi S; Al Dhanhani A; Sheek-Hussein MM; Bakoush O
    BMJ Open; 2016 Aug; 6(8):e010832. PubMed ID: 27481619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving blood pressure control among adults with CKD and diabetes: provider-focused quality improvement using electronic health records.
    Thomas B
    Adv Chronic Kidney Dis; 2011 Nov; 18(6):406-11. PubMed ID: 22098658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.